| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 11 |
| 1 | CAPECITABINE | 10 |
| 2 | HUMAN IMMUNOGLOBULIN G | 10 |
| 3 | OXALIPLATIN | 10 |
| 4 | ACETAMINOPHEN | 9 |
| 5 | DIPHENHYDRAMINE HYDROCHLORIDE | 9 |
| 6 | INFLIXIMAB | 9 |
| 7 | ERGOCALCIFEROL | 8 |
| 8 | INFLIXIMAB-DYYB | 8 |
| 9 | ACETAMINOPHEN 500MG | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 8 | 0.0023 |
| 1 | ALPHA1-PROTEINASE INHIBITOR (HUMAN) | 2 | 0.0010 |
| 2 | EPTINEZUMAB-JJMR | 7 | 0.0007 |
| 3 | .ALPHA.1-PROTEINASE INHIBITOR HUMAN | 2 | 0.0006 |
| 4 | KETAMINE HYDROCHLORIDE | 3 | 0.0006 |
| 5 | DACARBAZINE | 4 | 0.0005 |
| 6 | HUMAN IMMUNOGLOBULIN G | 10 | 0.0005 |
| 7 | BLEOMYCIN SULFATE | 4 | 0.0004 |
| 8 | ERGOCALCIFEROL | 8 | 0.0003 |
| 9 | KETOPROFEN | 3 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Calcitonin Gene-related Peptide Antagonist [EPC] | 7 | 0.0007 |
| 2 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 3 | Human Immunoglobulin G [EPC] | 10 | 0.0005 |
| 4 | Human alpha-1 Proteinase Inhibitor [EPC] | 2 | 0.0005 |
| 5 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 6 | Photoenhancer [EPC] | 1 | 0.0003 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 8 | Cannabinoid [EPC] | 1 | 0.0001 |
| 9 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |